OXCARBAZEPINE
NDC 70377-117, OXCARBAZEPINE, suspension, from Biocon Pharma Inc..
- Product NDC
- 70377-117
- Status
- Listed
- Labeler
- Biocon Pharma Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218278
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70377-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE60 mg/mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70377-117-11 | 70377011711 | 1 BOTTLE in 1 CARTON (70377-117-11) / 250 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/62dfed1d-4c5b-446d-97b3-bad9c33959ffNADAC price for package 70377011711
GET /v1/drugs/nadac/70377011711
Use it
Look up 70377-117 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70377-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70377-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.